BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 28236061)

  • 1. The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?
    Dias MM; Sorich MJ; Rowland A; Wiese MD; McKinnon RA
    Pharm Res; 2017 Aug; 34(8):1544-1550. PubMed ID: 28236061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individualizing pharmacogenomic test results in the context of the microbiome.
    Haga SB
    Per Med; 2020 Nov; 17(6):459-468. PubMed ID: 33026284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The challenges of implementing pharmacogenomic testing in the clinic.
    Moyer AM; Caraballo PJ
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now.
    Weitzel KW; Cavallari LH; Lesko LJ
    Pharm Res; 2017 Aug; 34(8):1551-1555. PubMed ID: 28466392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-interventional cardiologists' perspectives on the role of pharmacogenomic testing in cardiovascular medicine.
    Deininger KM; Page RL; Lee YM; Kauffman YS; Johnson SG; Oreschak K; Aquilante CL
    Per Med; 2019 Mar; 16(2):123-132. PubMed ID: 30543145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner-City Population.
    Lee YM; Manzoor BS; Cavallari LH; Nutescu EA
    Pharmacotherapy; 2018 Feb; 38(2):205-216. PubMed ID: 29286540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Personalized drug therapy based on genetics. Possibilities and examples from clinical practice].
    Stingl JC; Just KS; Kaumanns K; Schurig-Urbaniak M; Scholl C; von Mallek D; Brockmöller J
    Internist (Berl); 2016 Mar; 57(3):289-97. PubMed ID: 26830424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline.
    Miscio G; Paroni G; Bisceglia P; Gravina C; Urbano M; Lozupone M; Piccininni C; Prisciandaro M; Ciavarella G; Daniele A; Bellomo A; Panza F; Di Mauro L; Greco A; Seripa D
    Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):751-765. PubMed ID: 31512953
    [No Abstract]   [Full Text] [Related]  

  • 9. Personalized medicine: potential, barriers and contemporary issues.
    Sorich MJ; McKinnon RA
    Curr Drug Metab; 2012 Sep; 13(7):1000-6. PubMed ID: 22591350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital Health Applications for Pharmacogenetic Clinical Trials.
    Naik H; Palaniappan L; Ashley EA; Scott SA
    Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33114567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing Pharmacogenomic-Guided Medication Use With a Clinical Data Repository.
    Mathias PC; Hendrix N; Wang WJ; Keyloun K; Khelifi M; Tarczy-Hornoch P; Devine B
    Clin Pharmacol Ther; 2017 Aug; 102(2):340-348. PubMed ID: 28073152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards the integration of pharmacogenetics in psychiatry: a minimum, evidence-based genetic testing panel.
    Bousman C; Maruf AA; Müller DJ
    Curr Opin Psychiatry; 2019 Jan; 32(1):7-15. PubMed ID: 30299306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized medicine, pharmacogenomic and companion biomarker.
    Manceau H; Amrani K; Peoc'h K
    Ann Biol Clin (Paris); 2017 Dec; 75(6):631-636. PubMed ID: 29192598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpreting and Implementing Clinical Pharmacogenetic Tests: Perspectives From Service Providers.
    Hachad H; Ramsey LB; Scott SA
    Clin Pharmacol Ther; 2019 Aug; 106(2):298-301. PubMed ID: 31162629
    [No Abstract]   [Full Text] [Related]  

  • 15. Using pharmacogenetics in primary care.
    Murfin M
    JAAPA; 2019 Aug; 32(8):17-21. PubMed ID: 31290773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A stepwise approach to implementing pharmacogenetic testing in the primary care setting.
    Weitzel KW; Duong BQ; Arwood MJ; Owusu-Obeng A; Abul-Husn NS; Bernhardt BA; Decker B; Denny JC; Dietrich E; Gums J; Madden EB; Pollin TI; Wu RR; Haga SB; Horowitz CR
    Pharmacogenomics; 2019 Oct; 20(15):1103-1112. PubMed ID: 31588877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-guided warfarin therapy: current status.
    Tavares LC; Marcatto LR; Santos PCJL
    Pharmacogenomics; 2018 May; 19(7):667-685. PubMed ID: 29701078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany.
    Plöthner M; Ribbentrop D; Hartman JP; Frank M
    Adv Ther; 2016 Sep; 33(9):1461-80. PubMed ID: 27406232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of whole-genome sequencing-based pharmacogenetic profiling.
    Caspar SM; Schneider T; Stoll P; Meienberg J; Matyas G
    Pharmacogenomics; 2021 Feb; 22(3):177-190. PubMed ID: 33517770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics in psychiatric care, a call for uptake of available applications.
    Lunenburg CATC; Gasse C
    Psychiatry Res; 2020 Oct; 292():113336. PubMed ID: 32739644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.